ProShares Ultra Nasdaq Biotechnology (BIB)
NASDAQ: BIB · Real-Time Price · USD
79.57
-0.21 (-0.27%)
At close: Jan 2, 2026, 4:00 PM EST
81.65
+2.08 (2.62%)
After-hours: Jan 2, 2026, 7:15 PM EST
BIB Holdings Information
BIB is an equity ETF with a total of 272 individual holdings.
Total Holdings
272
Top 10 Percentage
151.09%
Asset Class
Equity
ETF Category
Trading--Leveraged Equity
Assets
83.78M
PE Ratio
n/a
Sector Allocation
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | n/a | NASDAQ BIO INDEX SWAP BNP PARIBAS | 35.70% |
| 2 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA | 33.24% |
| 3 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA | 24.02% |
| 4 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE | 16.93% |
| 5 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL | 15.67% |
| 6 | VRTX | Vertex Pharmaceuticals Incorporated | 6.00% |
| 7 | GILD | Gilead Sciences, Inc. | 5.59% |
| 8 | AMGN | Amgen Inc. | 5.43% |
| 9 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG | 4.31% |
| 10 | REGN | Regeneron Pharmaceuticals, Inc. | 4.20% |
| 11 | AZN | AstraZeneca PLC | 2.83% |
| 12 | ALNY | Alnylam Pharmaceuticals, Inc. | 2.77% |
| 13 | INSM | Insmed Incorporated | 1.96% |
| 14 | BIIB | Biogen Inc. | 1.36% |
| 15 | ARGX | argenx SE | 1.29% |
| 16 | UTHR | United Therapeutics Corporation | 1.11% |
| 17 | ILMN | Illumina, Inc. | 1.06% |
| 18 | INCY | Incyte Corporation | 1.02% |
| 19 | RPRX | Royalty Pharma plc | 0.87% |
| 20 | MEDP | Medpace Holdings, Inc. | 0.83% |
| 21 | RVMD | Revolution Medicines, Inc. | 0.81% |
| 22 | ROIV | Roivant Sciences Ltd. | 0.80% |
| 23 | BBIO | BridgeBio Pharma, Inc. | 0.78% |
| 24 | VTRS | Viatris Inc. | 0.76% |
| 25 | NBIX | Neurocrine Biosciences, Inc. | 0.75% |
As of Dec 31, 2025